搜索临床试验以:Antimetabolites, Antineoplastic
总计69793个结果
-
QED Therapeutics, Inc.Helsinn Healthcare SA终止FGFR2基因突变 | 晚期胆管癌大韩民国, 美国, 比利时, 西班牙, 台湾, 中国, 英国, 法国, 加拿大, 德国, 泰国, 意大利, 葡萄牙, 澳大利亚, 波多黎各
-
Aprea Therapeutics完全的
-
Dana-Farber Cancer InstituteSanofi; North American Consortium for Histiocytosis; St. Baldrick's Foundation; Cookies for Kids...主动,不招人
-
Fudan University主动,不招人
-
Celgene完全的
-
University of Southern CaliforniaBristol-Myers Squibb; Sanofi; Roche Global Development未知
-
John MascarenhasNational Cancer Institute (NCI); Incyte Corporation; Myeloproliferative Disorders-Research Consortium完全的
-
University of FloridaHyundai Hope On Wheels完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Sanofi-Synthelabo终止
-
Washington University School of Medicine完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)撤销
-
Royal Marsden NHS Foundation Trust完全的
-
Fudan UniversityShanghai Zhongshan Hospital; RenJi Hospital; First Hospital of China Medical University; Shanghai... 和其他合作者尚未招聘直肠癌 | 直肠肿瘤
-
Memorial Sloan Kettering Cancer Center招聘中
-
AIO-Studien-gGmbHAstraZeneca完全的胆管癌 | 胆管癌不可切除 | 胆囊癌 | 胆囊癌不可切除德国
-
Translational Genomics Research InstituteEli Lilly and Company撤销
-
University of Medicine and Dentistry of New JerseyBristol-Myers Squibb; Rutgers Cancer Institute of New Jersey终止
-
Eye & ENT Hospital of Fudan University招聘中
-
Guangzhou Lupeng Pharmaceutical Company LTD.招聘中
-
Sun Yat-sen UniversityWest China Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University招聘中